Ling Tong

This inventor holds 39 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 21 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Msd R&d (China) Co., Ltd.. Active years: 1999-2026.

USPTO Granted Patents = 39 (Patent Applications = 14)

% Patents Active = 76.9

CIPO Patents = 1

EPO Patents = 21 (Patent Applications = 23)

Average Co-Inventor Count = 11.0

ph-index = 9

Forward Citations = 266(Granted Patents)

Location History:

Princeton, NJ (US) (1999)
Warran, NJ (US) (2010)
Warren, NJ (US) (2006 - 2024)

Company Filing History:

18 out of 2,405

Merck Sharp + Dohme Corp.

Msd R&d (China) Co., Ltd.

patents

4. 2 out of 63

Merck Sharp & Dohme LLC

patents

5. 1 out of 1

Merck Msd (r&d) China Co., Ltd.

patent

6. 1 out of 204

Southern Research Institute

patents

7. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

PCSK9 Antagonists

Cannabinoid Receptor Ligands

Viral Disease Treatments

Allosteric Modulators

Glucosylceramide Synthase Inhibitors

Inflammatory Disorders

Heterocyclic Compounds

Pharmaceutical Compositions

ERK Inhibitors

Bicyclic Heterocycles

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559491 - Modified imidazopyridines as glucosylceramide synthase inhibitors (2026-02-24),

2. 12497405 - Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses (2025-12-16),

3. 12209145 - PCSK9 antagonist compounds (2025-01-28),

4. 11970479 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2024-04-30),

5. 11427616 - PCSK9 antagonist compounds (2022-08-30),

6. 11339156 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2022-05-24),

7. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2021-11-02),

8. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-10-19),

9. 10981902 - 5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-04-20),

10. 10933056 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-03-02),

11. 10836775 - 6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor (2020-11-17),

12. 10738062 - Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseases (2020-08-11),

13. 10646494 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases (2020-05-12),

14. 9828365 - Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases (2017-11-28),

15. 9555038 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases (2017-01-31),

Title: Inventor Ling Tong - Revolutionizing Technology

Introduction: Ling Tong, a visionary inventor based in Warren, NJ, is a pioneering woman in the field of technology and innovation.

Latest Patents: Ling Tong holds several groundbreaking patents in the realm of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Ling Tong has consistently pushed the boundaries of technological advancement, leading to numerous successful inventions that have transformed industries.

Collaborations: Throughout her career, Ling Tong has collaborated with top research institutions, leading companies, and innovative startups, fostering a culture of creativity and excellence in all her projects.

Conclusion: Ling Tong's relentless pursuit of innovation and her passion for creating a better future through technology make her a true trailblazer in the world of inventions.